Report from the 24th Congress of the European Association of Urology, Stockholm, Sweden, 17–21 March 2009, dedicated to renal carcinoma

10.4081/79 ◽  
2011 ◽  
Vol 3 (2) ◽  
Author(s):  
Chiara Paglino
Keyword(s):  
European Association ◽  
Renal Carcinoma ◽  
24Th Congress ◽  
European Association Of Urology

scholarly journals Report from the 24th Congress of the European Association of Urology, Stockholm, Sweden, 17–21 March 2009, dedicated to renal carcinoma

2011 ◽  
Vol 3 (2) ◽  
pp. 71
Author(s):  
Chiara Paglino
Keyword(s):  
European Association ◽  
Renal Carcinoma ◽  
Medical Oncology ◽  
Annual Congress ◽  
24Th Congress ◽  
European Association Of Urology

Once again, this year’s annual congress of the European Association of Urology (EAU) proved to be of great interest, not only for those more directly involved, the urologists, but also for who, like me, participated as an observer from the field of medical oncology...

European Association of Urology Guidelines on Urethral Stricture Disease (Part 1): Management of Male Urethral Stricture Disease

2021 ◽  
Author(s):  
Nicolaas Lumen ◽  
Felix Campos-Juanatey ◽  
Tamsin Greenwell ◽  
Francisco E. Martins ◽  
Nadir I. Osman ◽  
...  
Keyword(s):  
Urethral Stricture ◽  
European Association ◽  
Urethral Stricture Disease ◽  
European Association Of Urology

Comparison of UK and European Association of Urology (EAU) guidelines for kidney cancer management

2017 ◽  
Vol 11 (2) ◽  
pp. 132-138
Author(s):  
David Nicol
Keyword(s):  
Kidney Cancer ◽  
European Association ◽  
Treatment Modalities ◽  
Current Evidence ◽  
Specific Strength ◽  
Cancer Management ◽  
Funding Model ◽  
Cancer Networks ◽  
The Uk ◽  
European Association Of Urology

Clinical practice frequently utilises guidelines on how specific conditions should be managed. For urologists in the UK a range of sources are used as guidelines for the management of kidney cancer. These include documents from national bodies such as the National Institute for Health and Care Excellence (NICE), professional bodies as well as those prepared by individual groups of clinicians within regional cancer networks. In this article the European Association of Urology (EAU) guidelines on renal cell carcinoma are compared to guidelines used in the UK for this disease. Broadly consistent variations exist related to regional practice patterns, funding and the currency of the various guidelines. A specific strength of the EAU guidelines is the regular updating of these allowing incorporation of new evidence. These however do not consider the funding model for healthcare of the UK which dictates the availability of some treatment modalities and thus in some areas are not applicable. Current guidelines for kidney cancer developed within the UK are inconsistent and often outdated in terms of evidence sources. Broader use of the EAU guidelines within the economic restrictions of healthcare in the UK may result in a more consistent practise utilising current evidence sources in the management of kidney cancer.

Sign in / Sign up

Export Citation Format

Share Document